MAP3K1 and cancer: The results of KEGG pathway analysis demonstrated that pathways, including the cell cycle, DNA replication, cellular senescence, mismatch repair, platinum drug resistance, glioma, PD‐L1 expression and the PD‐1 checkpoint pathway in cancer were enriched in gliomas with high MAP3K1 expression (Figure 6A).